계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Commence Bio
company
About
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $400K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- May 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells. Commence aims to apply these methods in various inflammation-related disorders, including rheumatoid arthritis, by creating uniform cellular therapeutics with predictable behaviors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$400K
Commence Bio has raised a total of
$400K
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2012 | Grant | $400K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Commence Bio is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
